LIN
NASDAQ · Chemicals
Linde Plc
$482.74
+4.54 (+0.95%)
Financial Highlights (FY 2026)
Revenue
33.18B
Net Income
6.73B
Gross Margin
48.8%
Profit Margin
20.3%
Rev Growth
+0.6%
D/E Ratio
0.71
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 48.8% | 48.8% | 28.4% | 28.4% |
| Operating Margin | 26.2% | 23.6% | 12.4% | 11.8% |
| Profit Margin | 20.3% | 19.3% | 12.4% | 11.1% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 33.18B | 32.97B | 86.43B | 64.99B |
| Gross Profit | 16.20B | 16.10B | 24.58B | 18.48B |
| Operating Income | 8.71B | 7.79B | 10.71B | 7.67B |
| Net Income | 6.73B | 6.02B | 10.70B | 7.22B |
| Gross Margin | 48.8% | 48.8% | 28.4% | 28.4% |
| Operating Margin | 26.2% | 23.6% | 12.4% | 11.8% |
| Profit Margin | 20.3% | 19.3% | 12.4% | 11.1% |
| Rev Growth | +0.6% | +0.6% | +11.1% | +24.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 46.94B | 46.94B | 39.25B | 46.78B |
| Total Equity | 65.99B | 65.99B | 166.24B | 174.93B |
| D/E Ratio | 0.71 | 0.71 | 0.24 | 0.27 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 12.38B | 11.69B | 13.66B | 10.92B |
| Free Cash Flow | — | — | 5.87B | 5.32B |